Related Experiment Video
Updated: Jul 9, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart
Kriti Kalra1, Mohamad B Moumneh1, Michael G Nanna2
1Inova Center of Outcomes Research, Inova Heart and Vascular, Fairfax, VA, United States.
Insights
Managing stable ischemic heart disease (SIHD) in older adults requires a patient-centered approach. Focusing on holistic health outcomes and individual needs improves care for this high-risk population.
Area of Science:
- Gerontology
- Cardiology
- Geriatric Medicine
Background:
- The global population of older adults is rapidly expanding, leading to an increase in multiple chronic diseases, often exacerbated by cardiovascular conditions.
- Stable ischemic heart disease (SIHD) is a major cause of illness and death in older adults.
- Current SIHD management is suboptimal due to underrepresentation of older adults in clinical trials and insufficient consideration of biological aging, geriatric syndromes, and patient preferences.
Purpose of the Study:
- To highlight the unique health needs of older adults with SIHD.
- To advocate for a patient-centered approach that prioritizes holistic outcomes like functional capacity, cognitive health, mental well-being, and quality of life.
- To emphasize the importance of shared decision-making in treatment strategies for older adults.
Main Methods:
- This is a review article.
- It synthesizes current understanding of SIHD management in older adults.
- It focuses on the intersection of aging, chronic disease, and patient-centered care.
Main Results:
- Older adults have distinct needs that go beyond traditional cardiovascular outcomes.
- Holistic health outcomes (functional capacity, cognition, mental health, quality of life) are crucial for this population.
- An individualized, patient-centered approach is essential for effective SIHD management.
Conclusions:
- A shift towards patient-centered care and shared decision-making is necessary for managing SIHD in older adults.
- Addressing the unique needs of older adults promotes successful aging and improves cardiovascular care.
- Prioritizing patient preferences alongside clinical outcomes leads to more effective management of SIHD in the highest-risk population.
Abstract:
The global population of older adults is expanding rapidly resulting in a shift towards managing multiple chronic diseases that coexist and may be exacerbated by cardiovascular illness. Stable ischemic heart disease (SIHD) is a predominant contributor to morbidity and mortality in the older adult population. Although results from clinical trials demonstrate that chronological age is a predictor of poor health outcomes, the current management approach remains suboptimal due to insufficient representation of older adults in randomized trials and the inadequate consideration for the interaction between biological aging, concurrent geriatric syndromes, and patient preferences. A shift towards a more patient-centered approach is necessary for appropriately and effectively managing SIHD in the older adult population. In this review, we aim to demonstrate the distinctive needs of older adults who prioritize holistic health outcomes like functional capacity, cognitive abilities, mental health, and quality of life alongside the prevention of major adverse cardiovascular outcomes reported in cardiovascular clinical trials. An individualized, patient-centered approach that involves shared decision-making regarding outcome prioritization is needed when any treatment strategy is being considered. By prioritizing patients and addressing their unique needs for successful aging, we can provide more effective care to a patient population that exhibits the highest cardiovascular risks.
Related Concept Videos
Clinical Trials: Overview
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Longitudinal Research
Longitudinal Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

